ADI1P2

Across TCGA pan-cancer cohorts, ADI1P2 RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated ADI1P2 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher ADI1P2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated ADI1P2 expression acts as an unfavorable survival marker, although some lineages such as ESCA and OV show a favorable association.

MESO, READ, and CESC are the cancer types where ADI1P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	All	0.155	0.569	<.001	117	view →
READ	OS	Tertile	All	0.166	0.830	<.001	60	view →
CESC	OS	Tertile	All	0.269	0.609	.004	42	view →
SKCM	DFS	Tertile	IV	0.032	0.477	<.001	39	view →
ESCA	OS	Quartile	III,IV	0.705	0.320	.003	30	view →
KIRP	OS	Tertile	All	0.765	0.914	.003	30	view →
LAML	DFS	Median	All	0.308	0.600	.004	20	view →
KIRC	DFS	Tertile	IV	0.323	0.625	.043	18	view →
ACC	OS	Tertile	IV	0.327	0.633	.045	18	view →
THYM	DFS	Tertile	All	0.342	0.799	.003	15	view →
LUSC	OS	Tertile	All	0.336	0.418	.024	15	view →
KICH	DFS	Tertile	IV	0.269	0.784	.045	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

ADI1P2–MESO (OS)

Open the MESO breakdown →